gip/glp-1 agonists The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Alimentary Pharmacology & Therapeutics |

Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option

In the cohort analyses patients who initiated GLP-1 RAs did not differ in the hazard ratio (HR) for suicide or suicide attempts from SGLT-2 inhibitor users (HR: 0.93

FRIDAY, Aug

Pendulums GLP-1 Probiotic offers a natural solution by enhancing GLP-1 levels to help control appetite and regulate blood sugar

Heart failure (HF) affects 6 million people in the US, and type 2 diabetes (T2D) is a significant risk factor for HF

225 mg of Hericium erinaceus extract (equivalent to 1.8 g of dried mushroom), titrated to 30% polysaccharides